Clinical Trial Update: Bone Marrow Derived AC 133+ and Mono-Nuclear Cells (MNC) Implantation in Myocardial Infarction (MI) Patient [Phase 2, Phase 3]

View source ↗

Summary

Status update indicating completion of Phase 2/3 clinical trials evaluating implantation of bone marrow–derived AC133+ (CD133+) and mono-nuclear cells in patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Bone marrow-derived AC133+ and Mono-Nuclear Cells (MNC) implantation

Snippet

Sponsor: Royan Institute | Conditions: Myocardial Infarction | Phase 2, Phase 3 | Status: COMPLETED